Erratum to: Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study

Hori, Masatsugu; Nagai, Ryozo; Izumi, Tohru; Matsuzaki, Masunori

doi:10.1007/s00380-013-0373-7

Erratum to: Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study

Erratum
Published: 19 June 2013

Volume 29, page 248, (2014)
Cite this article

Download PDF

Heart and Vessels Aims and scope Submit manuscript

Erratum to: Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study

Download PDF

Masatsugu Hori¹,
Ryozo Nagai²,
Tohru Izumi³ &
…
Masunori Matsuzaki⁴

1379 Accesses
Explore all metrics

The Original Article was published on 05 April 2013

Erratum to: Heart Vessels DOI 10.1007/s00380-013-0340-3

Unfortunately, the below note was not included in the original publication.

“Masatsugu Hori, Ryozo Nagai and Tohru Izumi received lecture fees from Mitsubishi Tanabe Pharma Corporation”.

Author information

Authors and Affiliations

Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka, 537-8511, Japan
Masatsugu Hori
Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
Ryozo Nagai
Department of Cardio-Angiology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan
Tohru Izumi
Department of Medicine and Clinical Science, Division of Cardiology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi, 755-8505, Japan
Masunori Matsuzaki

Authors

Masatsugu Hori
View author publications
You can also search for this author in PubMed Google Scholar
Ryozo Nagai
View author publications
You can also search for this author in PubMed Google Scholar
Tohru Izumi
View author publications
You can also search for this author in PubMed Google Scholar
Masunori Matsuzaki
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masatsugu Hori.

Additional information

The online version of the original article can be found under doi:10.1007/s00380-013-0340-3.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hori, M., Nagai, R., Izumi, T. et al. Erratum to: Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study. Heart Vessels 29, 248 (2014). https://doi.org/10.1007/s00380-013-0373-7

Download citation

Published: 19 June 2013
Issue Date: March 2014
DOI: https://doi.org/10.1007/s00380-013-0373-7

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Erratum to: Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study

Erratum to: Heart Vessels DOI 10.1007/s00380-013-0340-3

Author information

Authors and Affiliations

Corresponding author

Additional information

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation